Tempus announces four abstracts accepted for presentation at the european society for medical oncology congress 2024

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today announced four abstracts were accepted for presentation at the european society for medical oncology (esmo) congress 2024, which convenes in barcelona, spain, from september 13-17, 2024. "esmo provides a great platform to share our recent research and advancements with the global oncology community, foster further collaboration, and drive.
TEM Ratings Summary
TEM Quant Ranking